Results 111 to 120 of about 3,086,890 (203)

ASSOCATION OF SERUM SEX HORMONE BINDING GLOBULIN WITH TYPE 2 DIABETES MELLITUS

Pakistan Armed Forces Medical Journal, 2016
Objective: To investigate the association of circulating levels of sex hormone binding globulin with type 2 diabetes mellitus. Study Design: Case control study. Place and Duration of Study: The study was conducted at the Department of Chemical Pathology,
Mehnaz Khattak, Jawwad Anis Khan, Asma Hayat, Tariq Mahmood Ahmad   +3 more
doaj   +2 more sources

Isoflavone supplementation reduced serum sex hormone-binding globulin concentration in postmenopausal women [PDF]

Universa Medicina, 2012
Introduction The bone loss that occurs with ageng in postmenopausal women is related to a decrease in serum levels of bioavailable estrogen and testosterone, which are mainly bound to sex hormone-binding globulin (SHBG) and albumin.
ML. Edy Parwanto, Yanti Indrawati, Herman Setiawan   +2 more
doaj  

Menopause and vascular endothelial health: Is it all about the oestrogen?

Experimental Physiology, EarlyView.
Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols, Allyson I. Schwab, Lyndsey E. DuBose, Kerrie L. Moreau, Megan M. Wenner   +4 more
wiley   +1 more source

Testosterone, sex hormone-binding globulin and risk of cardiovascular events : A report from the Outcome Reduction with an Initial Glargine Intervention trial

, 2019
Aims: Testosterone and its binding protein sex hormone-binding globulin have been associated with cardiovascular disease and dysglycaemia. However, information on the prognostic implication in patients at high cardiovascular risk with dysglycaemia is ...
Boman, Kurt,, Ryden, Lars, Mellbin, Linda G., Wang, Anne, Hess, Sibylle, Arver, Stefan, Lee, Shun Fu, Gerstein, Hertzel C.   +7 more
core   +1 more source

Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks

Experimental Physiology, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan, Stephanie Cowan, Chau Thien Tay, Lisa J. Moran, Ashley H. Ng   +4 more
wiley   +1 more source

Intramuscular pathways of maladaptation in overtraining syndrome

The Journal of Physiology, EarlyView.
Abstract figure legend The transition from adaptive overreaching to maladaptive overtraining and mechanisms through which excessive training load can lead to performance decline. Four interconnected pathophysiological domains are highlighted: neural fatigue, involving both central and peripheral components such as altered sensory feedback and reflex ...
Emily Shorter, Oscar Horwath, Sabrina Tzivia Barsky, Ferdinand von Walden, Johanna T. Lanner   +4 more
wiley   +1 more source

Comparison of Clinical, Metabolic, and Hormonal Profiles in Obese Versus Lean Women With Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
This meta‐analysis of 42 studies, including 5363 women with PCOS, found that obesity was associated with more severe reproductive, androgenic, metabolic, and cardiometabolic abnormalities. Lean PCOS also carried substantial metabolic risk, supporting phenotype‐informed assessment and cardiometabolic screening regardless of BMI.
Fatema Tuz Zahura Aalpona, Apurba Sarker, Lutfun Nahar, Md Abdul Bari Robel, A. B. M. Kamrul‐Hasan   +4 more
wiley   +1 more source

Multi-Target QSAR and Docking Study of Steroids Binding to Corticosteroid-Binding Globulin and Sex Hormone-Binding Globulin

, 2012
The QSAR and docking studies were performed on fifty seven steroids with binding affinities for corticosteroid-binding globulin (CBG) and eighty four steroids with binding affinities for sex hormone-binding globulin (SHBG).
Nikolić, Katarina, Agbaba, Danica, Filipić, Slavica   +2 more
core   +1 more source

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

Journal of Internal Medicine, Volume 300, Issue 5, Page 590-609, November 2026.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund, Johanna Melin, Anju E. Joham, Terhi T. Piltonen, D. Aled Rees, Helena J. Teede   +5 more
wiley   +1 more source

Sex-hormone-binding globulin gene polymorphisms and breast cancer risk in Caucasian women of Russia [PDF]

In our work, the associations of GWAS (genome-wide associative studies) impact for sex-hormone-binding globulin (SHBG)-level SNPs with the risk of breast cancer (BC) in the cohort of Caucasian women of Russia were ...
Churnosov, V., Reshetnikov, E., Pasenov, K., Ponomarenko, I., Churnosova, M., Ponomarenko, M., Aristova, I., Sorokina, I., Churnosov, M.   +8 more
core